Literature DB >> 3531207

Insulin and phorbol esters affect the maximum velocity rather than the half-saturation constant of 3-O-methylglucose transport in rat adipocytes.

A Martz, B K Mookerjee, C Y Jung.   

Abstract

The kinetics of the equilibrium exchange flux of 3-O-methylglucose (MeGlc) were examined in isolated rat adipocytes using a recently described technique (Whitesell, R. R., and Abumrad, N. A. (1985) J. Biol. Chem. 260, 2894-2899) in which the cells, under basal conditions, were reported to exhibit a high Km (35 mM) that was reduced (to 3 mM) upon treatment with insulin. When this technique was employed in the present study, the Km observed in basal adipocytes was 6.4 +/- 0.4 mM; insulin treatment did not affect this parameter (6.3 +/- 0.5 mM), although it increased the maximum velocity (phi max) 21-fold (from 3.0 +/- 0.3 to 63.7 +/- 1.1 nmol X min-1 X microliter of intracellular water-1). The large discrepancy in the basal Km values observed in the previous (35 mM) and the present (6.4 mM) studies is shown to be associated with relatively minor differences in basal MeGlc flux; these minor differences may reflect insufficient mixing of labeled MeGlc in the flux measurements of the previous study. In addition, the active phorbol ester, 12-O-tetradecanoylphorbol 13-acetate, at a concentration of 0.3 microM, caused a 2.8-fold elevation of phi max, with no modulation of Km. These results indicate that phi max, not Km, is the major kinetic parameter of hexose transport affected by insulin and phorbol esters, leading to enhancement of hexose uptake by the isolated rat adipocyte.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3531207

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Protein kinase C activators selectively inhibit insulin-stimulated system A transport activity in skeletal muscle at a post-receptor level.

Authors:  A Gumà; M Camps; M Palacín; X Testar; A Zorzano
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

Review 2.  The regulation of glucose transport in insulin-sensitive cells.

Authors:  H G Joost; T M Weber
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

3.  Enhancement of glucose transport by insulin at 37 degrees C in rat adipocytes is accounted for by increased Vmax.

Authors:  Y Okuno; J Gliemann
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

4.  Is there a link between impaired glucose metabolism and protein kinase C activity in the diabetic heart?

Authors:  S W Schaffer; C Ballard; M S Mozaffari
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

5.  Effect of osmolality and myo-inositol deprivation on the transport properties of myo-inositol in primary astrocyte cultures.

Authors:  R E Isaacks; A S Bender; C Y Kim; M D Norenberg
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

6.  Effect of ammonia and methionine sulfoximine on myo-inositol transport in cultured astrocytes.

Authors:  R E Isaacks; A S Bender; C Y Kim; Y F Shi; M D Norenberg
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

7.  Qualitative and quantitative comparison of glucose transport activity and glucose transporter concentration in plasma membranes from basal and insulin-stimulated rat adipose cells.

Authors:  H G Joost; T M Weber; S W Cushman
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

8.  Mechanism of mitogen-induced stimulation of glucose transport in human peripheral blood mononuclear cells. Evidence of an intracellular reserve pool of glucose carriers and their recruitment.

Authors:  D B Jacobs; T P Lee; C Y Jung; B K Mookerjee
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

9.  The potential role of GLUT4 transporters and insulin receptors in the hypoglycaemic activity of Ficus lutea acetone leaf extract.

Authors:  Oyinlola O Olaokun; Lyndy J McGaw; Maurice D Awouafack; Jacobus N Eloff; Vinny Naidoo
Journal:  BMC Complement Altern Med       Date:  2014-07-28       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.